As SDC3 has been implicated in the progression of ovarian [16], pancreatic [17], and renal cancers [18], we sought to determine whether the molecule contributes to the aggressive behavior of breast cancer cells, and if it could serve as a biomarker for the disease. This evidence concerns the gene SDC3 and renal carcinoma.